Related Experiment Video
Updated: Aug 6, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
Risk of Incident Dry Eye Disease Among Patients With Chronic Pain Conditions
Shannan Berzack1, Shon B Shmushkevich1, Charles Zhang2
1From the Herbert Wertheim College of Medicine (S.B., S.B.S.), Florida International University, Miami, Florida, USA; Bascom Palmer Eye Institute (S.B., S.B.S., C.Z., A.G.), University of Miami Miller School of Medicine, Miami, Florida, USA.
Objective:
To evaluate whether chronic pain conditions (CPCs) are associated with increased risk of incident dry eye disease (DED) and prescription-requiring DED in a large electronic health record network.
Design:
Retrospective cohort study.
Subjects, Participants, And/Or Controls:
Adults aged 18 years or older in the TriNetX Analytics Network (2005-2025) with a qualifying ophthalmology examination and no prior DED diagnosis. The exposure cohort included patients with at least one CPC diagnosis before the index visit; controls had no CPC diagnoses before or after the index visit. After 1:1 propensity score-matching, 538 364 patients were included per cohort. A validation cohort restricted to patients with age-related cataract included 506 763 matched patients per group.
Methods:
Patients were identified using ICD-10-CM, SNOMED, and CPT codes. Propensity score matching balanced demographics and comorbidities. Two outcomes were assessed at 1, 2, and 3 years after the index visit: incident DED, defined by a new diagnosis of dry eye syndrome or keratoconjunctivitis sicca not specified as Sjögren's, and prescription-requiring DED, defined by initiation of topical cyclosporine or lifitegrast. Risk ratios with 95% confidence intervals were calculated. Time-to-event analyses used Kaplan-Meier curves and multivariable Cox proportional hazards models.
Main Outcome Measures:
Incident DED and prescription-requiring DED.
Results:
Patients with at least one CPC diagnosis had significantly higher risk of incident DED compared with controls at all follow-up intervals. At 1 year, incident DED occurred in 3.34% of the CPC cohort versus 0.72% (RR 4.64; 95% CI, 4.49-4.81; P < .0001). At 3 years, cumulative incidence increased to 7.16% versus 1.50% (RR 4.78; 95% CI, 4.66-4.89; P < .0001). Prescription-requiring DED was also more common in the CPC cohort at 3 years (0.79% vs 0.30%; RR 2.60; 95% CI, 2.45-2.75). In multivariable Cox regression, CPCs were independently associated with increased hazard of incident DED (hazard ratio 4.85; 95% CI, 4.76-4.94; P < .0001). Findings were consistent in the validation cohort.
Conclusions:
CPCs are strongly associated with an increased risk of incident and prescription-requiring DED. These findings support consideration of CPCs as risk factors in the evaluation and management of DED and suggest that a subset of patients with DED may reflect broader pain-processing abnormalities.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Accessory Structures of the Eye
Glaucoma: Overview
Microbiome of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

